H. Michael Shepard
Overview
H. Michael Shepard received an average of $943K in total compensation, including $273K in salary, at Halozyme Therapeutics from 2009 to 2013.
2013Halozyme TherapeuticsVice President and Chief Scientific Officer
2012Halozyme TherapeuticsVice President and Chief Scientific Officer
2011Halozyme TherapeuticsVice President and Chief Scientific Officer
2010Halozyme TherapeuticsVice President and Chief Scientific Officer
2009Halozyme TherapeuticsVice President and Chief Scientific Officer
Source: SEC filings on April 7, 2014, April 11, 2013, and March 29, 2012.
Related executives
We found 21 more executives who work or worked at Halozyme Therapeutics.
Helen Torley
Halozyme Therapeutics
Chief Executive Officer
Masaru Matsuda
Halozyme Therapeutics
General Counsel
Michael LaBarre
Halozyme Therapeutics
Senior Vice President, Chief Technical Officer
Elaine Sun
Halozyme Therapeutics
Chief Financial Officer
Laurie Stelzer
Halozyme Therapeutics
Chief Financial Officer
Alison Armour
Halozyme Therapeutics
Former Senior Vice President, Head of Research & Development
Benjamin Hickey
Halozyme Therapeutics
Former Senior Vice President, Chief Commercial Officer
Harry Leonhardt
Halozyme Therapeutics